Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2007-11-30
2009-12-15
Kifle, Bruck (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C540S557000
Reexamination Certificate
active
07632830
ABSTRACT:
An agent for increasing the sugar-transporting capacity and an agent for preventing and/or treating diabetes, diabetic peripheral neuropathy, diabetic nephropathy, diabetic retinopathy, diabetic macroangiopathy, impaired glucose tolerance or adiposis, which contains a lactam compound or a pharmaceutically acceptable salt thereof as the active ingredient.
REFERENCES:
patent: 2004/0048847 (2004-03-01), Iino et al.
patent: 2005/0272641 (2005-12-01), Ikenoue et al.
patent: P0003394 (2001-08-01), None
patent: 11-171776 (1999-06-01), None
patent: 99/06403 (1999-02-01), None
Sorokina, et al., “Synthesis and Pharmacological Study of Derivatives of Pyrrolo[3,4-B]Benzo[1,5]Diazepine”, Pharmaceutical Chemistry Journal, vol. 25, No. 11, 1991, pp. 768-770.
Matsuo, et al., “Synthesis and Reaction of Dihydrofuro[3,4-B][1,5]Benzodiazepinones and Dihydropyrrolo[3,4-B][1,5]Benzodiazepinones”, Journal of the Pharamaceutical Society of Japan, vol. 106, No. 8, 1986, pp. 715-720.
Matsuo, et al., “Synthesis of the Novel Furo[3,4-B][1,5]Benzodiazepinone and Pyrrolo[3,4-B][1,5]Benzodiazepinone Systems”, Chem. Pharm. Bull., vol. 32, No. 9, pp. 3724-3729, 1984.
Augustin, et al., “A Simple Synthesis of Some New 2-Aryl-Substituted 2,5-Dihydro-1-H-1,5-Benzodiazepine-And 2,5-Dihydro-1,5-Benzothiaepin-3,4-Dicarboxylic N-Arylimides”, Communications, 1987, pp. 937-938.
Matsuo, et al., “10-Aryl-3,3-Dimethyl-2,3,4,10-Tetrahydro-1H-Pyrrolo[3,4-C][,5]Benzothiazepin-1-One”, Journal of the Pharmaceutical Society of Japan, vol. 104, No. 9, 1984, pp. 1004-1008.
Schmidt, et al., “Ring Construction Using 3-(Arylmethylene)-2,4(3H,5H)-Furandione: Synthesis of Pyrazolones and Furo[3,4-C][1,5]Benzothiazepinones”, J. Org. Chem., vol. 48, No. 23, 1983, pp. 4367-4370.
K. Matsuo, et al., “Synthesis and Reaction of 10-Aryl-3,4,9,10-Tetrahydro-1H-Thieno-[4,3-B][1,5]Benzodiazepin-1-Ones”, Chemistry Express, vol. 6, No. 7, 1991, pp. 495-498.
Hatanaka Toshihiro
Hirama Ryusuke
Iino Yukio
Ikenoue Takao
Kondo Nobuo
Ajinomoto Co. Inc.
Kifle Bruck
Oblon, Spivak McClelland, Maier & Neustadt, L.L.P.
LandOfFree
Lactam compounds and pharmaceutical use thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Lactam compounds and pharmaceutical use thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Lactam compounds and pharmaceutical use thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4145823